Who
Bassil I. Dahiyat
Director
Company insider
Files Form 4 as: Director, Kodiak Sciences; President & CEO, Xencor.
In numbers
- Trades disclosed
- 89
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $11.8M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Feb 2014
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,731 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,731 at $0.00 | filing |
| 6 Mar 2026filed 9 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $73K6,606 at $11.02 | filing |
| 6 Mar 2026filed 9 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $73K6,606 at $11.02 | filing |
| 5 Mar 2026filed 9 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $167K14,870 at $11.25 | filing |
| 5 Mar 2026filed 9 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $167K14,870 at $11.25 | filing |
| 3 Mar 2026filed 4 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $80K6,758 at $11.90 | filing |
| 3 Mar 2026filed 4 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $80K6,758 at $11.90 | filing |
| 2 Mar 2026filed 4 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —97,291 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —583,748 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —583,748 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —97,291 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —10,624 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $133K10,624 at $12.51 | filing |
| 19 Dec 2025filed 23 Dec 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —114,377 at $0.00 | filing |
| 19 Dec 2025filed 23 Dec 2025 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $1.4M114,377 at $12.51 | filing |
| 19 Dec 2025filed 23 Dec 2025 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $1.8M114,377 at $15.71 | filing |
| 30 Jun 2025filed 2 Jul 2025 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $268K19,716 at $13.60 | filing |
| 4 Mar 2025filed 5 Mar 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —329,236 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.